Ekawat, Hemophilia, Thailand
Sanofi's global specialty care business unit focuses on rare diseases, rare blood disorders, neurology, immunology, and oncology.
Sanofi's ambition is to leverage science and innovation to improve people’s lives and be the industry leader in immunology and oncology.
Its approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities.
Sanofi's specialty care business unit supports access to treatment through humanitarian programs to help ensure that appropriate treatment reaches all those who need it.
Sanofi has a strong pipeline with a significant portion of its R&D spending concentrated on specialty care.